España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Merck
Palantir Deepens Relationship With Ringier To Help It Transform Into A Digital-First, Global Media Company
Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research
Barron's Picks And Pans: Bank Mergers, Comcast, Dogs of the Dow, Square And More
Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research
Barron's Picks And Pans: Bank Mergers, Comcast, Dogs of the Dow, Square And More
Barron's Picks And Pans: Merck, Walmart, Zoetis And More
Benzinga's Bulls And Bears Of The Week: Apple, Ford, Merck, Uber And More
Barron's Picks And Pans: Merck, Walmart, Zoetis And More
Benzinga's Bulls And Bears Of The Week: Apple, Ford, Merck, Uber And More
Pharma Large And Mid-Caps Race Against COVID-19
10 International ADR Companies That Are Conducting Virtual Investor Presentations This Week
Sponsored
Read More...
Merck Recent News
Benzinga's Bulls And Bears Of The Week: Merck, Nike, Target And More
Barron's Picks And Pans: GM, Kraft Heinz, Tesla, Under Armour And More
Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More
Barron's Picks And Pans: Corning, Merck, Microsoft And More
Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Barron's Picks And Pans: Gold, Energy, Dividends And More
Can Merck And Pfizer Beat Low Expectations?
Dow Earnings: High Hopes For Chevron, Johnson & Johnson
This Week's Dow Earnings: High Expectations For DuPont And Visa
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Merck And Pfizer Earnings: Will They Beat Expectations Again?
Shares Of Merck Dip Lower Following Q4 Print
Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient
Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA'
Barron's Recap: What's Next?
Barron's Recap: Airline Stocks Ready To Soar
Bank Of America On Merck: 'MAGNIF-TECOS!'
Apple & Other Earnings Expected To Dominate The Week Of April 27
Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern
Merck Shares Teetering On The Brink Of A Further Downside Correction
Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More
Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More
Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level